Knight Therapeutics Inc KHTRF

Primary Symbol: T.GUD

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Increasing revenues through pandemic!

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Sep 14, 2022 7:20pm

191 Views

Post# 34963172

RE:RE:Increasing revenues through pandemic!

BTW for anyone new in this forum Gold and Mugsy is the same person with different alias pedling a lost cause GUD for ten years and nothing to show for other than huse loses as high as 90% one caluculating the opportunity loss and his/her avarage cost near $8

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec